2017-17871. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Start SignatureTable 1—List of Information Collections Approved by OMB
Title of collection OMB control No. Date approval expires Premarket Notification Submission 510(k), Subpart E 0910-0120 6/30/2020 Institutional Review Boards 0910-0130 6/30/2020 Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions 0910-0233 6/30/2020 Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) 0910-0471 6/30/2020 Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products 0910-0543 6/30/2020 Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act 0910-0679 6/30/2020 Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion 0910-0681 6/30/2020 Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug, and Cosmetic Act 0910-0762 6/30/2020 Certification of Identity for Freedom of Information Act and Privacy Act Requests 0910-0832 6/30/2020 FDA Advisory Committee Membership Nominations 0910-0833 6/30/2020 Dated: August 18, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-17871 Filed 8-22-17; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 08/23/2017
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2017-17871
- Pages:
- 40009-40009 (1 pages)
- Docket Numbers:
- Docket Nos. FDA-2013-N-0804, FDA-2013-N-1163, FDA-2013-N-1393, FDA-2017-N-0084, FDA-2013-N-0731, FDA-2009-D-0008, FDA-2013-N-0868, FDA-2013-D-0117, FDA-2016-N-2066, FDA-2017-N-0366
- PDF File:
- 2017-17871.pdf